{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T02:18:35Z","timestamp":1794968315276,"version":"4.9.1"},"reference-count":235,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1038\/s41585-020-0286-z","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T18:03:31Z","timestamp":1582049011000},"page":"232-250","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":414,"title":["The microbiome and gynaecological cancer development, prevention and therapy"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5190-2173","authenticated-orcid":false,"given":"Pawe\u0142","family":"\u0141aniewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehra Esra","family":"Ilhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8540-5917","authenticated-orcid":false,"given":"Melissa M.","family":"Herbst-Kralovetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,18]]},"reference":[{"key":"286_CR1","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nm.4517","volume":"24","author":"JA Gilbert","year":"2018","unstructured":"Gilbert, J. A. et al. Current understanding of the human microbiome. Nat. Med. 24, 392\u2013400 (2018).","journal-title":"Nat. Med."},{"key":"286_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-015-0094-5","volume":"3","author":"JR Marchesi","year":"2015","unstructured":"Marchesi, J. R. & Ravel, J. The vocabulary of microbiome research: a proposal. Microbiome 3, 31 (2015).","journal-title":"Microbiome"},{"key":"286_CR3","first-page":"14","volume":"6","author":"TM Santiago-Rodriguez","year":"2015","unstructured":"Santiago-Rodriguez, T. M., Ly, M., Bonilla, N. & Pride, D. T. The human urine virome in association with urinary tract infections. Front. Microbiol. 6, 14 (2015).","journal-title":"Front. Microbiol."},{"key":"286_CR4","doi-asserted-by":"publisher","first-page":"175628481983662","DOI":"10.1177\/1756284819836620","volume":"12","author":"I Mukhopadhya","year":"2019","unstructured":"Mukhopadhya, I., Segal, J. P., Carding, S. R., Hart, A. L. & Hold, G. L. The gut virome: the \u2018missing link\u2019 between gut bacteria and host immunity? Ther. Adv. Gastroenterol. 12, 1756284819836620 (2019).","journal-title":"Ther. Adv. Gastroenterol."},{"key":"286_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-017-0373-4","volume":"5","author":"AK Nash","year":"2017","unstructured":"Nash, A. K. et al. The gut mycobiome of the Human Microbiome Project healthy cohort. Microbiome 5, 153 (2017).","journal-title":"Microbiome"},{"key":"286_CR6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1080\/21505594.2016.1237332","volume":"8","author":"LL Bradford","year":"2017","unstructured":"Bradford, L. L. & Ravel, J. The vaginal mycobiome: a contemporary perspective on fungi in women\u2019s health and diseases. Virulence 8, 342\u2013351 (2017).","journal-title":"Virulence"},{"key":"286_CR7","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41585-019-0192-4","volume":"16","author":"A Garretto","year":"2019","unstructured":"Garretto, A., Miller-Ensminger, T., Wolfe, A. J. & Putonti, C. Bacteriophages of the lower urinary tract. Nat. Rev. Urol. 16, 422\u2013432 (2019).","journal-title":"Nat. Rev. Urol."},{"key":"286_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002533","volume":"14","author":"R Sender","year":"2016","unstructured":"Sender, R., Fuchs, S. & Milo, R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 14, e1002533 (2016).","journal-title":"PLoS Biol."},{"key":"286_CR9","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1126\/science.1124234","volume":"312","author":"SR Gill","year":"2006","unstructured":"Gill, S. R. et al. Metagenomic analysis of the human distal gut microbiome. Science 312, 1355\u20131359 (2006).","journal-title":"Science"},{"key":"286_CR10","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.7150\/jca.20497","volume":"8","author":"H Raskov","year":"2017","unstructured":"Raskov, H., Burcharth, J. & Pommergaard, H. C. Linking gut microbiota to colorectal cancer. J. Cancer 8, 3378\u20133395 (2017).","journal-title":"J. Cancer"},{"key":"286_CR11","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/ijc.31098","volume":"142","author":"HX Liu","year":"2018","unstructured":"Liu, H. X. et al. Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects. Int. J. Cancer 142, 769\u2013778 (2018).","journal-title":"Int. J. Cancer"},{"key":"286_CR12","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3389\/fimmu.2018.00208","volume":"9","author":"JM Baker","year":"2018","unstructured":"Baker, J. M., Chase, D. M. & Herbst-Kralovetz, M. M. Uterine microbiota: residents, tourists, or invaders? Front. Immunol. 9, 208 (2018).","journal-title":"Front. Immunol."},{"key":"286_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrurol.2014.361","volume":"12","author":"SA Whiteside","year":"2015","unstructured":"Whiteside, S. A., Razvi, H., Dave, S., Reid, G. & Burton, J. P. The microbiome of the urinary tract \u2014 a role beyond infection. Nat. Rev. Urol. 12, 81\u201390 (2015).","journal-title":"Nat. Rev. Urol."},{"key":"286_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03968-5","volume":"9","author":"K Thomas-White","year":"2018","unstructured":"Thomas-White, K. et al. Culturing of female bladder bacteria reveals an interconnected urogenital microbiota. Nat. Commun. 9, 1557 (2018).","journal-title":"Nat. Commun."},{"key":"286_CR15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/1471-2180-11-244","volume":"11","author":"H Siddiqui","year":"2011","unstructured":"Siddiqui, H., Nederbragt, A. J., Lagesen, K., Jeansson, S. L. & Jakobsen, K. S. Assessing diversity of the female urine microbiota by high throughput sequencing of 16S rDNA amplicons. BMC Microbiol. 11, 244 (2011).","journal-title":"BMC Microbiol."},{"key":"286_CR16","doi-asserted-by":"publisher","first-page":"e01283","DOI":"10.1128\/mBio.01283-14","volume":"5","author":"MM Pearce","year":"2014","unstructured":"Pearce, M. M. et al. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. MBio 5, e01283\u201301214 (2014).","journal-title":"MBio"},{"key":"286_CR17","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.euf.2016.11.001","volume":"4","author":"IM Aragon","year":"2018","unstructured":"Aragon, I. M. et al. The urinary tract microbiome in health and disease. Eur. Urol. Focus. 4, 128\u2013138 (2018).","journal-title":"Eur. Urol. Focus."},{"key":"286_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrurol.2017.167","volume":"15","author":"KS Sfanos","year":"2018","unstructured":"Sfanos, K. S., Yegnasubramanian, S., Nelson, W. G. & De Marzo, A. M. The inflammatory microenvironment and microbiome in prostate cancer development. Nat. Rev. Urol. 15, 11\u201324 (2018).","journal-title":"Nat. Rev. Urol."},{"key":"286_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0368-y","volume":"8","author":"MR Walther-Antonio","year":"2016","unstructured":"Walther-Antonio, M. R. et al. Potential contribution of the uterine microbiome in the development of endometrial cancer. Genome Med. 8, 122 (2016).","journal-title":"Genome Med."},{"key":"286_CR20","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.1602","volume":"4","author":"H Verstraelen","year":"2016","unstructured":"Verstraelen, H. et al. Characterisation of the human uterine microbiome in non-pregnant women through deep sequencing of the V1-2 region of the 16S rRNA gene. PeerJ 4, e1602 (2016).","journal-title":"PeerJ"},{"key":"286_CR21","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ajog.2016.09.075","volume":"215","author":"I Moreno","year":"2016","unstructured":"Moreno, I. et al. Evidence that the endometrial microbiota has an effect on implantation success or failure. Am. J. Obstet. Gynecol. 215, 684\u2013703 (2016).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"286_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10815-015-0614-z","volume":"33","author":"JM Franasiak","year":"2016","unstructured":"Franasiak, J. M. et al. Endometrial microbiome at the time of embryo transfer: next-generation sequencing of the 16S ribosomal subunit. J. Assist. Reprod. Genet. 33, 129\u2013136 (2016).","journal-title":"J. Assist. Reprod. Genet."},{"key":"286_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00901-0","volume":"8","author":"C Chen","year":"2017","unstructured":"Chen, C. et al. The microbiota continuum along the female reproductive tract and its relation to uterine-related diseases. Nat. Commun. 8, 875 (2017).","journal-title":"Nat. Commun."},{"key":"286_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-016-0161-6","volume":"4","author":"M Zozaya","year":"2016","unstructured":"Zozaya, M. et al. Bacterial communities in penile skin, male urethra, and vaginas of heterosexual couples with and without bacterial vaginosis. Microbiome 4, 16 (2016).","journal-title":"Microbiome"},{"key":"286_CR25","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41585-019-0250-y","volume":"16","author":"S Altmae","year":"2019","unstructured":"Altmae, S., Franasiak, J. M. & Mandar, R. The seminal microbiome in health and disease. Nat. Rev. Urol. 16, 703\u2013721 (2019).","journal-title":"Nat. Rev. Urol."},{"key":"286_CR26","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1073\/pnas.1002611107","volume":"108","author":"J Ravel","year":"2011","unstructured":"Ravel, J. et al. Vaginal microbiome of reproductive-age women. Proc. Natl Acad. Sci. USA 108, 4680\u20134687 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"286_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature11234","volume":"486","author":"Human Microbiome Project Consortium","year":"2012","unstructured":"Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 486, 207\u2013214 (2012).","journal-title":"Nature"},{"key":"286_CR28","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1093\/infdis\/jiw184","volume":"214","author":"DH Martin","year":"2016","unstructured":"Martin, D. H. & Marrazzo, J. M. The vaginal microbiome: current understanding and future directions. J. Infect. Dis. 214, S36\u2013S41 (2016).","journal-title":"J. Infect. Dis."},{"key":"286_CR29","first-page":"331","volume":"89","author":"KL Nunn","year":"2016","unstructured":"Nunn, K. L. & Forney, L. J. Unraveling the dynamics of the human vaginal microbiome. Yale J. Biol. Med. 89, 331\u2013337 (2016).","journal-title":"Yale J. Biol. Med."},{"key":"286_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.anaerobe.2017.02.020","volume":"45","author":"MA Beamer","year":"2017","unstructured":"Beamer, M. A. et al. Bacterial species colonizing the vagina of healthy women are not associated with race. Anaerobe 45, 40\u201343 (2017).","journal-title":"Anaerobe"},{"key":"286_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12198-6","volume":"7","author":"V Jespers","year":"2017","unstructured":"Jespers, V. et al. A longitudinal analysis of the vaginal microbiota and vaginal immune mediators in women from sub-Saharan Africa. Sci. Rep. 7, 11974 (2017).","journal-title":"Sci. Rep."},{"key":"286_CR32","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1128\/CVI.00762-14","volume":"22","author":"JK Kyongo","year":"2015","unstructured":"Kyongo, J. K. et al. Cross-sectional analysis of selected genital tract immunological markers and molecular vaginal microbiota in sub-Saharan African women, with relevance to HIV risk and prevention. Clin. Vaccine Immunol. 22, 526\u2013538 (2015).","journal-title":"Clin. Vaccine Immunol."},{"key":"286_CR33","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1086\/315109","volume":"180","author":"MA Antonio","year":"1999","unstructured":"Antonio, M. A., Hawes, S. E. & Hillier, S. L. The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J. Infect. Dis. 180, 1950\u20131956 (1999).","journal-title":"J. Infect. Dis."},{"key":"286_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.tim.2017.07.008","volume":"26","author":"JA Younes","year":"2018","unstructured":"Younes, J. A. et al. Women and their microbes: the unexpected friendship. Trends Microbiol. 26, 16\u201332 (2018).","journal-title":"Trends Microbiol."},{"key":"286_CR35","first-page":"1936","volume":"7","author":"EA Miller","year":"2016","unstructured":"Miller, E. A., Beasley, D. E., Dunn, R. R. & Archie, E. A. Lactobacilli dominance and vaginal pH: why is the human vaginal microbiome unique? Front. Microbiol. 7, 1936 (2016).","journal-title":"Front. Microbiol."},{"key":"286_CR36","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.trsl.2012.02.008","volume":"22","author":"RJ Hickey","year":"2012","unstructured":"Hickey, R. J., Zhou, X., Pierson, J. D., Ravel, J. & Forney, L. J. Understanding vaginal microbiome complexity from an ecological perspective. Transl Res. 22, 267\u2013282 (2012).","journal-title":"Transl Res."},{"key":"286_CR37","doi-asserted-by":"crossref","unstructured":"\u0141aniewski, P. & Herbst-Kralovetz, M. in Encyclopedia of Reproduction Vol. 2 (ed M. K. Skinner) 353-359 (Academic Press: Elsevier, 2018).","DOI":"10.1016\/B978-0-12-801238-3.64406-9"},{"key":"286_CR38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1476-0711-10-8","volume":"10","author":"MA Graver","year":"2011","unstructured":"Graver, M. A. & Wade, J. J. The role of acidification in the inhibition of Neisseria gonorrhoeae by vaginal lactobacilli during anaerobic growth. Ann. Clin. Microbiol. Antimicrob. 10, 8 (2011).","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"286_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107758","volume":"9","author":"Z Gong","year":"2014","unstructured":"Gong, Z., Luna, Y., Yu, P. & Fan, H. Lactobacilli inactivate Chlamydia trachomatis through lactic acid but not H2O2. PLoS One 9, e107758 (2014).","journal-title":"PLoS One"},{"key":"286_CR40","first-page":"19","volume":"60","author":"C Conti","year":"2009","unstructured":"Conti, C., Malacrino, C. & Mastromarino, P. Inhibition of herpes simplex virus type 2 by vaginal lactobacilli. J. Physiol. Pharmacol. 60, 19\u201326 (2009).","journal-title":"J. Physiol. Pharmacol."},{"key":"286_CR41","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00055-18","volume":"3","author":"D Tyssen","year":"2018","unstructured":"Tyssen, D. et al. Anti-HIV-1 activity of lactic acid in human cervicovaginal fluid. mSphere 3, e00055-18 (2018).","journal-title":"mSphere"},{"key":"286_CR42","first-page":"13","volume":"60","author":"PA Cadieux","year":"2009","unstructured":"Cadieux, P. A., Burton, J., Devillard, E. & Reid, G. Lactobacillus by-products inhibit the growth and virulence of uropathogenic Escherichia coli. J. Physiol. Pharmacol. 60, 13\u201318 (2009).","journal-title":"J. Physiol. Pharmacol."},{"key":"286_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080074","volume":"8","author":"DE O'Hanlon","year":"2013","unstructured":"O\u2019Hanlon, D. E., Moench, T. R. & Cone, R. A. Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota. PLoS One 8, e80074 (2013).","journal-title":"PLoS One"},{"key":"286_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-018-0418-3","volume":"6","author":"G Tachedjian","year":"2018","unstructured":"Tachedjian, G., O\u2019Hanlon, D. E. & Ravel, J. The implausible \u201cin vivo\u201d role of hydrogen peroxide as an antimicrobial factor produced by vaginal microbiota. Microbiome 6, 29 (2018).","journal-title":"Microbiome"},{"key":"286_CR45","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12866-016-0663-1","volume":"16","author":"A Maldonado-Barragan","year":"2016","unstructured":"Maldonado-Barragan, A., Caballero-Guerrero, B., Martin, V., Ruiz-Barba, J. L. & Rodriguez, J. M. Purification and genetic characterization of gassericin E, a novel co-culture inducible bacteriocin from Lactobacillus gasseri EV1461 isolated from the vagina of a healthy woman. BMC Microbiol. 16, 37 (2016).","journal-title":"BMC Microbiol."},{"key":"286_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153553","volume":"11","author":"P Mirmonsef","year":"2016","unstructured":"Mirmonsef, P. et al. Glycogen levels in undiluted genital fluid and their relationship to vaginal pH, estrogen, and progesterone. PLoS One 11, e0153553 (2016).","journal-title":"PLoS One"},{"key":"286_CR47","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/ismej.2007.12","volume":"1","author":"X Zhou","year":"2007","unstructured":"Zhou, X. et al. Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women. ISME J. 1, 121\u2013133 (2007).","journal-title":"ISME J."},{"key":"286_CR48","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1099\/mic.0.081034-0","volume":"160","author":"JM Fettweis","year":"2014","unstructured":"Fettweis, J. M. et al. Differences in vaginal microbiome in African American women versus women of European ancestry. Microbiology 160, 2272\u20132282 (2014).","journal-title":"Microbiology"},{"key":"286_CR49","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/OLQ.0000000000000972","volume":"46","author":"K Peebles","year":"2019","unstructured":"Peebles, K., Velloza, J., Balkus, J. E., McClelland, R. S. & Barnabas, R. V. High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis. Sex. Transm. Dis. 46, 304\u2013311 (2019).","journal-title":"Sex. Transm. Dis."},{"key":"286_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181135","volume":"12","author":"H Borgdorff","year":"2017","unstructured":"Borgdorff, H. et al. The association between ethnicity and vaginal microbiota composition in Amsterdam, the Netherlands. PLoS One 12, e0181135 (2017).","journal-title":"PLoS One"},{"key":"286_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25879-7","volume":"8","author":"P \u0141aniewski","year":"2018","unstructured":"\u0141aniewski, P. et al. Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women. Sci. Rep. 8, 7593 (2018).","journal-title":"Sci. Rep."},{"key":"286_CR52","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/OLQ.0b013e31815e4179","volume":"35","author":"JF Peipert","year":"2008","unstructured":"Peipert, J. F. et al. Bacterial vaginosis, race, and sexually transmitted infections: does race modify the association? Sex. Transm. Dis. 35, 363\u2013367 (2008).","journal-title":"Sex. Transm. Dis."},{"key":"286_CR53","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/OLQ.0b013e318156a5d0","volume":"35","author":"TL Cherpes","year":"2008","unstructured":"Cherpes, T. L., Hillier, S. L., Meyn, L. A., Busch, J. L. & Krohn, M. A. A delicate balance: risk factors for acquisition of bacterial vaginosis include sexual activity, absence of hydrogen peroxide-producing lactobacilli, black race, and positive herpes simplex virus type 2 serology. Sex. Transm. Dis. 35, 78\u201383 (2008).","journal-title":"Sex. Transm. Dis."},{"key":"286_CR54","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ajog.2013.05.006","volume":"209","author":"C Kenyon","year":"2013","unstructured":"Kenyon, C., Colebunders, R. & Crucitti, T. The global epidemiology of bacterial vaginosis: a systematic review. Am. J. Obstet. Gynecol. 209, 505\u2013523 (2013).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"286_CR55","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/AOG.0000000000001932","volume":"129","author":"FM Lewis","year":"2017","unstructured":"Lewis, F. M., Bernstein, K. T. & Aral, S. O. Vaginal microbiome and its relationship to behavior, sexual health, and sexually transmitted diseases. Obstet. Gynecol. 129, 643\u2013654 (2017).","journal-title":"Obstet. Gynecol."},{"key":"286_CR56","doi-asserted-by":"publisher","first-page":"132ra152","DOI":"10.1126\/scitranslmed.3003605","volume":"4","author":"P Gajer","year":"2012","unstructured":"Gajer, P. et al. Temporal dynamics of the human vaginal microbiota. Sci. Transl Med. 4, 132ra152 (2012).","journal-title":"Sci. Transl Med."},{"key":"286_CR57","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00460-13","volume":"4","author":"SS Witkin","year":"2013","unstructured":"Witkin, S. S. et al. Influence of vaginal bacteria and D- and L-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections. MBio 4, e00460-13 (2013).","journal-title":"MBio"},{"key":"286_CR58","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41591-019-0465-8","volume":"25","author":"MG Serrano","year":"2019","unstructured":"Serrano, M. G. et al. Racioethnic diversity in the dynamics of the vaginal microbiome during pregnancy. Nat. Med. 25, 1001\u20131011 (2019).","journal-title":"Nat. Med."},{"key":"286_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14943-3","volume":"8","author":"TM Nelson","year":"2018","unstructured":"Nelson, T. M. et al. Cigarette smoking is associated with an altered vaginal tract metabolomic profile. Sci. Rep. 8, 852 (2018).","journal-title":"Sci. Rep."},{"key":"286_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-471","volume":"14","author":"RM Brotman","year":"2014","unstructured":"Brotman, R. M. et al. Association between cigarette smoking and the vaginal microbiota: a pilot study. BMC Infect. Dis. 14, 471 (2014).","journal-title":"BMC Infect. Dis."},{"key":"286_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210825","volume":"14","author":"MC Sabo","year":"2019","unstructured":"Sabo, M. C. et al. Association between vaginal washing and vaginal bacterial concentrations. PLoS One 14, e0210825 (2019).","journal-title":"PLoS One"},{"key":"286_CR62","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/aje\/kwn103","volume":"168","author":"RM Brotman","year":"2008","unstructured":"Brotman, R. M. et al. A longitudinal study of vaginal douching and bacterial vaginosis \u2014 a marginal structural modeling analysis. Am. J. Epidemiol. 168, 188\u2013196 (2008).","journal-title":"Am. J. Epidemiol."},{"key":"286_CR63","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.3945\/jn.111.140541","volume":"141","author":"ME Thoma","year":"2011","unstructured":"Thoma, M. E. et al. Bacterial vaginosis is associated with variation in dietary indices. J. Nutr. 141, 1698\u20131704 (2011).","journal-title":"J. Nutr."},{"key":"286_CR64","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1093\/jn\/137.9.2128","volume":"137","author":"YH Neggers","year":"2007","unstructured":"Neggers, Y. H. et al. Dietary intake of selected nutrients affects bacterial vaginosis in women. J. Nutr. 137, 2128\u20132133 (2007).","journal-title":"J. Nutr."},{"key":"286_CR65","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ajog.2018.10.076","volume":"219","author":"EM Wilkinson","year":"2018","unstructured":"Wilkinson, E. M., Herbst-Kralovetz, M. M. & Brotman, R. M. Clinical and personal lubricants alter cell viability, cytotoxicity and mucin production in human vaginal epithelial cell models. Am. J. Obstet. Gynecol. 219, 638 (2018).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"286_CR66","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.maturitas.2016.05.015","volume":"91","author":"AL Muhleisen","year":"2016","unstructured":"Muhleisen, A. L. & Herbst-Kralovetz, M. M. Menopause and the vaginal microbiome. Maturitas 91, 42\u201350 (2016).","journal-title":"Maturitas"},{"key":"286_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/2049-2618-2-4","volume":"2","author":"R Romero","year":"2014","unstructured":"Romero, R. et al. The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome 2, 4 (2014).","journal-title":"Microbiome"},{"key":"286_CR68","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41585-018-0104-z","volume":"15","author":"L Karstens","year":"2018","unstructured":"Karstens, L. et al. Community profiling of the urinary microbiota: considerations for low-biomass samples. Nat. Rev. Urol. 15, 735\u2013749 (2018).","journal-title":"Nat. Rev. Urol."},{"key":"286_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-017-0268-4","volume":"5","author":"ME Perez-Munoz","year":"2017","unstructured":"Perez-Munoz, M. E., Arrieta, M. C., Ramer-Tait, A. E. & Walter, J. A critical assessment of the \u201csterile womb\u201d and \u201cin utero colonization\u201d hypotheses: implications for research on the pioneer infant microbiome. Microbiome 5, 48 (2017).","journal-title":"Microbiome"},{"key":"286_CR70","first-page":"1581","volume":"8","author":"RL Fang","year":"2016","unstructured":"Fang, R. L. et al. Barcoded sequencing reveals diverse intrauterine microbiomes in patients suffering with endometrial polyps. Am. J. Transl Res. 8, 1581\u20131592 (2016).","journal-title":"Am. J. Transl Res."},{"key":"286_CR71","doi-asserted-by":"publisher","first-page":"611.e1","DOI":"10.1016\/j.ajog.2014.11.043","volume":"212","author":"CM Mitchell","year":"2015","unstructured":"Mitchell, C. M. et al. Colonization of the upper genital tract by vaginal bacterial species in nonpregnant women. Am. J. Obstet. Gynecol. 212, 611.e1\u2013611.e9 (2015).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"286_CR72","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.fertnstert.2015.10.012","volume":"104","author":"JM Franasiak","year":"2015","unstructured":"Franasiak, J. M. & Scott, R. T. Jr. Reproductive tract microbiome in assisted reproductive technologies. Fertil. Steril. 104, 1364\u20131371 (2015).","journal-title":"Fertil. Steril."},{"key":"286_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014116","volume":"5","author":"DE Nelson","year":"2010","unstructured":"Nelson, D. E. et al. Characteristic male urine microbiomes associate with asymptomatic sexually transmitted infection. PLoS One 5, e14116 (2010).","journal-title":"PLoS One"},{"key":"286_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036298","volume":"7","author":"DE Nelson","year":"2012","unstructured":"Nelson, D. E. et al. Bacterial communities of the coronal sulcus and distal urethra of adolescent males. PLoS One 7, e36298 (2012).","journal-title":"PLoS One"},{"key":"286_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019709","volume":"6","author":"Q Dong","year":"2011","unstructured":"Dong, Q. et al. The microbial communities in male first catch urine are highly similar to those in paired urethral swab specimens. PLoS One 6, e19709 (2011).","journal-title":"PLoS One"},{"key":"286_CR76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008422","volume":"5","author":"LB Price","year":"2010","unstructured":"Price, L. B. et al. The effects of circumcision on the penis microbiome. PLoS One 5, e8422 (2010).","journal-title":"PLoS One"},{"key":"286_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0110152","volume":"9","author":"SL Weng","year":"2014","unstructured":"Weng, S. L. et al. Bacterial communities in semen from men of infertile couples: metagenomic sequencing reveals relationships of seminal microbiota to semen quality. PLoS One 9, e110152 (2014).","journal-title":"PLoS One"},{"key":"286_CR78","first-page":"243","volume":"58","author":"SG Dawson","year":"1982","unstructured":"Dawson, S. G., Ison, C. A., Csonka, G. & Easmon, C. S. Male carriage of Gardnerella vaginalis. Br. J. Vener. Dis. 58, 243\u2013245 (1982).","journal-title":"Br. J. Vener. Dis."},{"key":"286_CR79","first-page":"127","volume":"58","author":"GR Kinghorn","year":"1982","unstructured":"Kinghorn, G. R., Jones, B. M., Chowdhury, F. H. & Geary, I. Balanoposthitis associated with Gardnerella vaginalis infection in men. Br. J. Vener. Dis. 58, 127\u2013129 (1982).","journal-title":"Br. J. Vener. Dis."},{"key":"286_CR80","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1071\/SH17087","volume":"15","author":"KM Olson","year":"2018","unstructured":"Olson, K. M., Boohaker, L. J., Schwebke, J. R., Aslibekyan, S. & Muzny, C. A. Comparisons of vaginal flora patterns among sexual behaviour groups of women: implications for the pathogenesis of bacterial vaginosis. Sex. Health 15, 61\u201367 (2018).","journal-title":"Sex. Health"},{"key":"286_CR81","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1136\/sextrans-2018-053824","volume":"95","author":"CA Muzny","year":"2019","unstructured":"Muzny, C. A., Lensing, S. Y., Aaron, K. J. & Schwebke, J. R. Incubation period and risk factors support sexual transmission of bacterial vaginosis in women who have sex with women. Sex. Transm. Infect. 95, 511\u2013515 (2019).","journal-title":"Sex. Transm. Infect."},{"key":"286_CR82","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1093\/cid\/ciu1130","volume":"60","author":"LA Vodstrcil","year":"2015","unstructured":"Vodstrcil, L. A. et al. Incident bacterial vaginosis (BV) in women who have sex with women is associated with behaviors that suggest sexual transmission of BV. Clin. Infect. Dis. 60, 1042\u20131053 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"286_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141905","volume":"10","author":"DS Forcey","year":"2015","unstructured":"Forcey, D. S. et al. Factors associated with bacterial vaginosis among women who have sex with women: a systematic review. PLoS One 10, e0141905 (2015).","journal-title":"PLoS One"},{"key":"286_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-174","volume":"10","author":"DE Fouts","year":"2012","unstructured":"Fouts, D. E. et al. Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury. J. Transl Med. 10, 174 (2012).","journal-title":"J. Transl Med."},{"key":"286_CR85","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1128\/JCM.02876-13","volume":"52","author":"EE Hilt","year":"2014","unstructured":"Hilt, E. E. et al. Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J. Clin. Microbiol. 52, 871\u2013876 (2014).","journal-title":"J. Clin. Microbiol."},{"key":"286_CR86","doi-asserted-by":"publisher","first-page":"34","DOI":"10.21037\/atm.2016.11.62","volume":"5","author":"L Brubaker","year":"2017","unstructured":"Brubaker, L. & Wolfe, A. J. The female urinary microbiota, urinary health and common urinary disorders. Ann. Transl Med. 5, 34 (2017).","journal-title":"Ann. Transl Med."},{"key":"286_CR87","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fmed.2019.00178","volume":"6","author":"M Carda-Dieguez","year":"2019","unstructured":"Carda-Dieguez, M. et al. Variations in vaginal, penile, and oral microbiota after sexual intercourse: a case report. Front. Med. 6, 178 (2019).","journal-title":"Front. Med."},{"key":"286_CR88","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1086\/430926","volume":"192","author":"MA Antonio","year":"2005","unstructured":"Antonio, M. A., Rabe, L. K. & Hillier, S. L. Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. J. Infect. Dis. 192, 394\u2013398 (2005).","journal-title":"J. Infect. Dis."},{"key":"286_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-9-167","volume":"9","author":"NA El Aila","year":"2009","unstructured":"El Aila, N. A. et al. Identification and genotyping of bacteria from paired vaginal and rectal samples from pregnant women indicates similarity between vaginal and rectal microflora. BMC Infect. Dis. 9, 167 (2009).","journal-title":"BMC Infect. Dis."},{"key":"286_CR90","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.chom.2011.10.003","volume":"10","author":"CS Plottel","year":"2011","unstructured":"Plottel, C. S. & Blaser, M. J. Microbiome and malignancy. Cell Host Microbe 10, 324\u2013335 (2011).","journal-title":"Cell Host Microbe"},{"key":"286_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-253","volume":"10","author":"R Flores","year":"2012","unstructured":"Flores, R. et al. Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. J. Transl Med. 10, 253 (2012).","journal-title":"J. Transl Med."},{"key":"286_CR92","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.maturitas.2017.06.025","volume":"103","author":"JM Baker","year":"2017","unstructured":"Baker, J. M., Al-Nakkash, L. & Herbst-Kralovetz, M. M. Estrogen-gut microbiome axis: physiological and clinical implications. Maturitas 103, 45\u201353 (2017).","journal-title":"Maturitas"},{"key":"286_CR93","first-page":"1","volume":"61","author":"Schistosomes, liver flukes and Helicobacter pylori","year":"1994","unstructured":"Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7\u201314 June 1994. IARC Monogr. Eval. Carcinog. Risks Hum. 61, 1\u2013241 (1994).","journal-title":"IARC Monogr. Eval. Carcinog. Risks Hum."},{"key":"286_CR94","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.canlet.2013.08.016","volume":"345","author":"F Wang","year":"2014","unstructured":"Wang, F., Meng, W., Wang, B. & Qiao, L. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 345, 196\u2013202 (2014).","journal-title":"Cancer Lett."},{"key":"286_CR95","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S0140-6736(79)91315-1","volume":"1","author":"JC Welton","year":"1979","unstructured":"Welton, J. C., Marr, J. S. & Friedman, S. M. Association between hepatobiliary cancer and typhoid carrier state. Lancet 1, 791\u2013794 (1979).","journal-title":"Lancet"},{"key":"286_CR96","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1056\/NEJMoa031887","volume":"350","author":"M Lecuit","year":"2004","unstructured":"Lecuit, M. et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N. Engl. J. Med. 350, 239\u2013248 (2004).","journal-title":"N. Engl. J. Med."},{"key":"286_CR97","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1600-0560.1997.tb01318.x","volume":"24","author":"L Cerroni","year":"1997","unstructured":"Cerroni, L., Zochling, N., Putz, B. & Kerl, H. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J. Cutan. Pathol. 24, 457\u2013461 (1997).","journal-title":"J. Cutan. Pathol."},{"key":"286_CR98","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1200\/JCO.2011.41.4466","volume":"30","author":"AJ Ferreri","year":"2012","unstructured":"Ferreri, A. J. et al. Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial. J. Clin. Oncol. 30, 2988\u20132994 (2012).","journal-title":"J. Clin. Oncol."},{"key":"286_CR99","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1089\/vim.2016.0109","volume":"30","author":"N Akram","year":"2017","unstructured":"Akram, N. et al. Oncogenic role of tumor viruses in humans. Viral Immunol. 30, 20\u201327 (2017).","journal-title":"Viral Immunol."},{"key":"286_CR100","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.aaa4972","volume":"348","author":"WS Garrett","year":"2015","unstructured":"Garrett, W. S. Cancer and the microbiota. Science 348, 80\u201386 (2015).","journal-title":"Science"},{"key":"286_CR101","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/nrc3610","volume":"13","author":"RF Schwabe","year":"2013","unstructured":"Schwabe, R. F. & Jobin, C. The microbiome and cancer. Nat. Rev. Cancer 13, 800\u2013812 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"286_CR102","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.smim.2017.04.003","volume":"32","author":"M Kang","year":"2017","unstructured":"Kang, M. & Martin, A. Microbiome and colorectal cancer: unraveling host-microbiota interactions in colitis-associated colorectal cancer development. Semin. Immunol. 32, 3\u201313 (2017).","journal-title":"Semin. Immunol."},{"key":"286_CR103","doi-asserted-by":"publisher","first-page":"24285","DOI":"10.1073\/pnas.1912129116","volume":"116","author":"I Sobhani","year":"2019","unstructured":"Sobhani, I. et al. Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures. Proc. Natl Acad. Sci. USA 116, 24285\u201324295 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"286_CR104","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.smim.2017.08.001","volume":"32","author":"J Chen","year":"2017","unstructured":"Chen, J., Domingue, J. C. & Sears, C. L. Microbiota dysbiosis in select human cancers: evidence of association and causality. Semin. Immunol. 32, 25\u201334 (2017).","journal-title":"Semin. Immunol."},{"key":"286_CR105","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1158\/1940-6207.CAPR-16-0249","volume":"10","author":"SV Rajagopala","year":"2017","unstructured":"Rajagopala, S. V. et al. The human microbiome and cancer. Cancer Prev. Res. 10, 226\u2013234 (2017).","journal-title":"Cancer Prev. Res."},{"key":"286_CR106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006480","volume":"13","author":"LE Fulbright","year":"2017","unstructured":"Fulbright, L. E., Ellermann, M. & Arthur, J. C. The microbiome and the hallmarks of cancer. PLoS Pathog. 13, e1006480 (2017).","journal-title":"PLoS Pathog."},{"key":"286_CR107","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.chom.2016.03.007","volume":"19","author":"AR Moschen","year":"2016","unstructured":"Moschen, A. R. et al. Lipocalin 2 protects from inflammation and tumorigenesis associated with gut microbiota alterations. Cell Host Microbe 19, 455\u2013469 (2016).","journal-title":"Cell Host Microbe"},{"key":"286_CR108","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201847638","volume":"20","author":"MR Rubinstein","year":"2019","unstructured":"Rubinstein, M. R. et al. Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt\/beta-catenin modulator Annexin A1. EMBO Rep. 20, e47638 (2019).","journal-title":"EMBO Rep."},{"key":"286_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2351-9","volume":"16","author":"N Liu","year":"2016","unstructured":"Liu, N. et al. Helicobacter pylori promotes angiogenesis depending on Wnt\/beta-catenin-mediated vascular endothelial growth factor via the cyclooxygenase-2 pathway in gastric cancer. BMC Cancer 16, 321 (2016).","journal-title":"BMC Cancer"},{"key":"286_CR110","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.celrep.2019.01.006","volume":"26","author":"PK Zadora","year":"2019","unstructured":"Zadora, P. K. et al. Integrated phosphoproteome and transcriptome analysis reveals Chlamydia-induced epithelial-to-mesenchymal transition in host cells. Cell Rep. 26, 1286\u20131302 e1288 (2019).","journal-title":"Cell Rep."},{"key":"286_CR111","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ygyno.2015.04.036","volume":"138","author":"D Chase","year":"2015","unstructured":"Chase, D., Goulder, A., Zenhausern, F., Monk, B. & Herbst-Kralovetz, M. The vaginal and gastrointestinal microbiomes in gynecologic cancers: a review of applications in etiology, symptoms and treatment. Gynecol. Oncol. 138, 190\u2013200 (2015).","journal-title":"Gynecol. Oncol."},{"key":"286_CR112","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"286_CR113","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3322\/caac.21314","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel, R. L. et al. Cancer statistics for Hispanics\/Latinos, 2015. CA Cancer J. Clin. 65, 457\u2013480 (2015).","journal-title":"CA Cancer J. Clin."},{"key":"286_CR114","doi-asserted-by":"publisher","first-page":"661","DOI":"10.15585\/mmwr.mm6526a1","volume":"65","author":"LJ Viens","year":"2016","unstructured":"Viens, L. J. et al. Human papillomavirus-associated cancers \u2014 United States, 2008\u20132012. Morb. Mortal. Wkly Rep. 65, 661\u2013666 (2016).","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"286_CR115","first-page":"444","volume":"7","author":"M Marsh","year":"1956","unstructured":"Marsh, M. Original site of cervical carcinoma; topographical relationship of carcinoma of the cervix to the external os and to the squamocolumnar junction. Obstet. Gynecol. 7, 444\u2013452 (1956).","journal-title":"Obstet. Gynecol."},{"key":"286_CR116","doi-asserted-by":"publisher","first-page":"10516","DOI":"10.1073\/pnas.1202684109","volume":"109","author":"M Herfs","year":"2012","unstructured":"Herfs, M. et al. A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer. Proc. Natl Acad. Sci. USA 109, 10516\u201310521 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"286_CR117","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers, J. M. et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189, 12\u201319 (1999).","journal-title":"J. Pathol."},{"key":"286_CR118","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.tim.2014.02.009","volume":"22","author":"N Shulzhenko","year":"2014","unstructured":"Shulzhenko, N., Lyng, H., Sanson, G. F. & Morgun, A. Menage a trois: an evolutionary interplay between human papillomavirus, a tumor, and a woman. Trends Microbiol. 22, 345\u2013353 (2014).","journal-title":"Trends Microbiol."},{"key":"286_CR119","doi-asserted-by":"publisher","first-page":"E267","DOI":"10.3390\/v9100267","volume":"9","author":"PE Gravitt","year":"2017","unstructured":"Gravitt, P. E. & Winer, R. L. Natural history of HPV infection across the lifespan: role of viral latency. Viruses 9, E267 (2017).","journal-title":"Viruses"},{"key":"286_CR120","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/infdis\/jix333","volume":"216","author":"MD Ryser","year":"2017","unstructured":"Ryser, M. D., Rositch, A. & Gravitt, P. E. Modeling of US human papillomavirus (HPV) seroprevalence by age and sexual behavior indicates an increasing trend of hpv infection following the sexual revolution. J. Infect. Dis. 216, 604\u2013611 (2017).","journal-title":"J. Infect. Dis."},{"key":"286_CR121","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.annepidem.2017.10.004","volume":"27","author":"RC Eldridge","year":"2017","unstructured":"Eldridge, R. C. et al. Smoking and subsequent human papillomavirus infection: a mediation analysis. Ann. Epidemiol. 27, 724\u2013730.e721 (2017).","journal-title":"Ann. Epidemiol."},{"key":"286_CR122","first-page":"1021","volume":"10","author":"PE Castle","year":"2001","unstructured":"Castle, P. E. et al. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol. Biomarkers Prev. 10, 1021\u20131027 (2001).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"286_CR123","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/OLQ.0b013e318255aeef","volume":"39","author":"M Mhatre","year":"2012","unstructured":"Mhatre, M. et al. Cervical intraepithelial neoplasia is associated with genital tract mucosal inflammation. Sex. Transm. Dis. 39, 591\u2013597 (2012).","journal-title":"Sex. Transm. Dis."},{"key":"286_CR124","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/sti.2010.044354","volume":"87","author":"M Lehtinen","year":"2011","unstructured":"Lehtinen, M. et al. Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia. Sex. Transm. Infect. 87, 372\u2013376 (2011).","journal-title":"Sex. Transm. Infect."},{"key":"286_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/srep16865","volume":"5","author":"A Mitra","year":"2015","unstructured":"Mitra, A. et al. Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity. Sci. Rep. 5, 16865 (2015).","journal-title":"Sci. Rep."},{"key":"286_CR126","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153274","volume":"11","author":"A Audirac-Chalifour","year":"2016","unstructured":"Audirac-Chalifour, A. et al. Cervical microbiome and cytokine profile at various stages of cervical cancer: a pilot study. PLoS One 11, e0153274 (2016).","journal-title":"PLoS One"},{"key":"286_CR127","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ebiom.2019.04.028","volume":"44","author":"ZE Ilhan","year":"2019","unstructured":"Ilhan, Z. E. et al. Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling. EBioMedicine 44, 675\u2013690 (2019).","journal-title":"EBioMedicine"},{"key":"286_CR128","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1086\/427777","volume":"191","author":"DH Watts","year":"2005","unstructured":"Watts, D. H. et al. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J. Infect. Dis. 191, 1129\u20131139 (2005).","journal-title":"J. Infect. Dis."},{"key":"286_CR129","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-10","volume":"11","author":"E Gillet","year":"2011","unstructured":"Gillet, E. et al. Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: a meta-analysis. BMC Infect. Dis. 11, 10 (2011).","journal-title":"BMC Infect. Dis."},{"key":"286_CR130","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1258\/ijsa.2012.011342","volume":"23","author":"YL Guo","year":"2012","unstructured":"Guo, Y. L., You, K., Qiao, J., Zhao, Y. M. & Geng, L. Bacterial vaginosis is conducive to the persistence of HPV infection. Int. J. STD AIDS 23, 581\u2013584 (2012).","journal-title":"Int. J. STD AIDS"},{"key":"286_CR131","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-271","volume":"13","author":"W Gao","year":"2013","unstructured":"Gao, W., Weng, J., Gao, Y. & Chen, X. Comparison of the vaginal microbiota diversity of women with and without human papillomavirus infection: a cross-sectional study. BMC Infect. Dis. 13, 271 (2013).","journal-title":"BMC Infect. Dis."},{"key":"286_CR132","volume":"8","author":"JE Lee","year":"2013","unstructured":"Lee, J. E. et al. Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort. PLoS One 8, e6351 (2013).","journal-title":"PLoS One"},{"key":"286_CR133","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1093\/infdis\/jiu330","volume":"210","author":"RM Brotman","year":"2014","unstructured":"Brotman, R. M. et al. Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection. J. Infect. Dis. 210, 1723\u20131733 (2014).","journal-title":"J. Infect. Dis."},{"key":"286_CR134","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09842-6","volume":"7","author":"M Di Paola","year":"2017","unstructured":"Di Paola, M. et al. Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection. Sci. Rep. 7, 10200 (2017).","journal-title":"Sci. Rep."},{"key":"286_CR135","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27980-3","volume":"8","author":"H Tuominen","year":"2018","unstructured":"Tuominen, H., Rautava, S., Syrjanen, S., Collado, M. C. & Rautava, J. HPV infection and bacterial microbiota in the placenta, uterine cervix and oral mucosa. Sci. Rep. 8, 9787 (2018).","journal-title":"Sci. Rep."},{"key":"286_CR136","doi-asserted-by":"publisher","first-page":"674.e1","DOI":"10.1016\/j.cmi.2015.02.026","volume":"21","author":"HY Oh","year":"2015","unstructured":"Oh, H. Y. et al. The association of uterine cervical microbiota with an increased risk for cervical intraepithelial neoplasia in Korea. Clin. Microbiol. Infect. 21, 674.e1\u2013674.e9 (2015).","journal-title":"Clin. Microbiol. Infect."},{"key":"286_CR137","first-page":"9","volume":"21","author":"N Brusselaers","year":"2018","unstructured":"Brusselaers, N., Shrestha, S., Van De Wijgert, J. & Verstraelen, H. Vaginal dysbiosis, and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis. Am. J. Obstet. Gynecol. 21, 9\u201318.e8 (2018).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"286_CR138","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/1471-0528.15854","volume":"127","author":"J Norenhag","year":"2020","unstructured":"Norenhag, J. et al. The vaginal microbiota, HPV and cervical dysplasia: a systematic review and network meta-analysis. BJOG 127, 171\u2013180 (2020).","journal-title":"BJOG"},{"key":"286_CR139","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/infdis\/jiz325","volume":"220","author":"H Wang","year":"2019","unstructured":"Wang, H. et al. Associations of cervicovaginal lactobacilli with high-risk HPV infection, cervical intraepithelial neoplasia, and cancer: a systematic review and meta-analysis. J. Infect. Dis. 220, 1243\u20131254 (2019).","journal-title":"J. Infect. Dis."},{"key":"286_CR140","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.18632\/oncotarget.13676","volume":"8","author":"FF Mehta","year":"2017","unstructured":"Mehta, F. F., Baik, S. & Chung, S. H. Recurrence of cervical cancer and its resistance to progestin therapy in a mouse model. Oncotarget 8, 2372\u20132380 (2017).","journal-title":"Oncotarget"},{"key":"286_CR141","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206539","volume":"13","author":"LI Larmour","year":"2018","unstructured":"Larmour, L. I. et al. A patient derived xenograft model of cervical cancer and cervical dysplasia. PLoS One 13, e0206539 (2018).","journal-title":"PLoS One"},{"key":"286_CR142","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/path.4656","volume":"238","author":"J Doorbar","year":"2016","unstructured":"Doorbar, J. Model systems of human papillomavirus-associated disease. J. Pathol. 238, 166\u2013179 (2016).","journal-title":"J. Pathol."},{"key":"286_CR143","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.virusres.2016.12.004","volume":"231","author":"ND Christensen","year":"2017","unstructured":"Christensen, N. D., Budgeon, L. R., Cladel, N. M. & Hu, J. Recent advances in preclinical model systems for papillomaviruses. Virus Res. 231, 108\u2013118 (2017).","journal-title":"Virus Res."},{"key":"286_CR144","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1093\/infdis\/jiw130","volume":"214","author":"MM Herbst-Kralovetz","year":"2016","unstructured":"Herbst-Kralovetz, M. M., Pyles, R. B., Ratner, A. J., Sycuro, L. K. & Mitchell, C. New systems for studying intercellular interactions in bacterial vaginosis. J. Infect. Dis. 214, S6\u2013S13 (2016).","journal-title":"J. Infect. Dis."},{"key":"286_CR145","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059539","volume":"8","author":"NM Gilbert","year":"2013","unstructured":"Gilbert, N. M., Lewis, W. G. & Lewis, A. L. Clinical features of bacterial vaginosis in a murine model of vaginal infection with Gardnerella vaginalis. PLoS One 8, e59539 (2013).","journal-title":"PLoS One"},{"key":"286_CR146","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nrmicro2423","volume":"8","author":"J Barrila","year":"2010","unstructured":"Barrila, J. et al. Organotypic 3D cell culture models: using the rotating wall vessel to study host-pathogen interactions. Nat. Rev. Microbiol. 8, 791\u2013801 (2010).","journal-title":"Nat. Rev. Microbiol."},{"key":"286_CR147","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz514","author":"J Gardner","year":"2019","unstructured":"Gardner, J. et al. IL-36gamma is elevated in cervicovaginal epithelial cells in women with bacterial vaginosis and in vitro after infection with microbes associated with bacterial vaginosis. J. Infect. Dis. https:\/\/doi.org\/10.1093\/infdis\/jiz514 (2019).","journal-title":"J. Infect. Dis."},{"key":"286_CR148","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1093\/infdis\/jiu004","volume":"209","author":"SY Doerflinger","year":"2014","unstructured":"Doerflinger, S. Y., Throop, A. L. & Herbst-Kralovetz, M. M. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner. J. Infect. Dis. 209, 1989\u20131999 (2014).","journal-title":"J. Infect. Dis."},{"key":"286_CR149","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1095\/biolreprod.112.103366","volume":"87","author":"AL Radtke","year":"2012","unstructured":"Radtke, A. L., Quayle, A. J. & Herbst-Kralovetz, M. M. Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model. Biol. Reprod. 87, 132 (2012).","journal-title":"Biol. Reprod."},{"key":"286_CR150","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1095\/biolreprod.109.080408","volume":"82","author":"BE Hjelm","year":"2010","unstructured":"Hjelm, B. E., Berta, A. N., Nickerson, C. A., Arntzen, C. J. & Herbst-Kralovetz, M. M. Development and characterization of a three-dimensional organotypic human vaginal epithelial cell model. Biol. Reprod. 82, 617\u2013627 (2010).","journal-title":"Biol. Reprod."},{"key":"286_CR151","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01049-16","volume":"85","author":"P \u0141aniewski","year":"2017","unstructured":"\u0141aniewski, P., Gomez, A., Hire, G., So, M. & Herbst-Kralovetz, M. M. Human three-dimensional endometrial epithelial cell model to study host interactions with vaginal bacteria and Neisseria gonorrhoeae. Infect. Immun. 85, e01049-16 (2017).","journal-title":"Infect. Immun."},{"key":"286_CR152","first-page":"3868","volume":"62","author":"AL Radtke","year":"2012","unstructured":"Radtke, A. L. & Herbst-Kralovetz, M. M. Culturing and applications of rotating wall vessel bioreactor derived 3D epithelial cell models. J. Vis. Exp. 62, 3868 (2012).","journal-title":"J. Vis. Exp."},{"key":"286_CR153","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1093\/infdis\/jit101","volume":"207","author":"CL McGowin","year":"2013","unstructured":"McGowin, C. L., Radtke, A. L., Abraham, K., Martin, D. H. & Herbst-Kralovetz, M. Mycoplasma genitalium infection activates cellular host defense and inflammation pathways in a 3-dimensional human endocervical epithelial cell model. J. Infect. Dis. 207, 1857\u20131868 (2013).","journal-title":"J. Infect. Dis."},{"key":"286_CR154","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43849-5","volume":"9","author":"P \u0141aniewski","year":"2019","unstructured":"\u0141aniewski, P. et al. Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis. Sci. Rep. 9, 7333 (2019).","journal-title":"Sci. Rep."},{"key":"286_CR155","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00204-15","volume":"6","author":"S Srinivasan","year":"2015","unstructured":"Srinivasan, S. et al. Metabolic signatures of bacterial vaginosis. MBio 6, e00204-15 (2015).","journal-title":"MBio"},{"key":"286_CR156","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova, N. N. & Thompson, C. B. The emerging hallmarks of cancer metabolism. Cell Metab. 23, 27\u201347 (2016).","journal-title":"Cell Metab."},{"key":"286_CR157","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1097\/AOG.0000000000000605","volume":"125","author":"JA Rauh-Hain","year":"2015","unstructured":"Rauh-Hain, J. A. et al. Racial disparities in treatment of high-grade endometrial cancer in the Medicare population. Obstet. Gynecol. 125, 843\u2013851 (2015).","journal-title":"Obstet. Gynecol."},{"key":"286_CR158","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fonc.2016.00036","volume":"6","author":"S Chatterjee","year":"2016","unstructured":"Chatterjee, S., Gupta, D., Caputo, T. A. & Holcomb, K. Disparities in gynecological malignancies. Front. Oncol. 6, 36 (2016).","journal-title":"Front. Oncol."},{"key":"286_CR159","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jsbmb.2007.09.020","volume":"108","author":"A Doll","year":"2008","unstructured":"Doll, A. et al. Novel molecular profiles of endometrial cancer-new light through old windows. J. Steroid Biochem. Mol. Biol. 108, 221\u2013229 (2008).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"286_CR160","doi-asserted-by":"publisher","first-page":"318.e1","DOI":"10.1016\/j.ajog.2019.05.024","volume":"221","author":"KM Doll","year":"2019","unstructured":"Doll, K. M. & Winn, A. N. Assessing endometrial cancer risk among US women: long-term trends using hysterectomy-adjusted analysis. Am. J. Obstet. Gynecol. 221, 318.e1\u2013318.e9 (2019).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"286_CR161","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ajog.2017.09.016","volume":"218","author":"KM Doll","year":"2018","unstructured":"Doll, K. M., Snyder, C. R. & Ford, C. L. Endometrial cancer disparities: a race-conscious critique of the literature. Am. J. Obstet. Gynecol. 218, 474\u2013482 e472 (2018).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"286_CR162","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1677\/ERC-07-0064","volume":"15","author":"NE Allen","year":"2008","unstructured":"Allen, N. E. et al. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr. Relat. Cancer 15, 485\u2013497 (2008).","journal-title":"Endocr. Relat. Cancer"},{"key":"286_CR163","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1677\/ERC-10-0053","volume":"17","author":"L Dossus","year":"2010","unstructured":"Dossus, L. et al. Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study. Endocr. Relat. Cancer 17, 1007\u20131019 (2010).","journal-title":"Endocr. Relat. Cancer"},{"key":"286_CR164","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1053\/j.gastro.2009.03.030","volume":"136","author":"H Tilg","year":"2009","unstructured":"Tilg, H., Moschen, A. R. & Kaser, A. Obesity and the microbiota. Gastroenterology 136, 1476\u20131483 (2009).","journal-title":"Gastroenterology"},{"key":"286_CR165","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3748\/wjg.v20.i4.908","volume":"20","author":"M Candela","year":"2014","unstructured":"Candela, M. et al. Inflammation and colorectal cancer, when microbiota-host mutualism breaks. World J. Gastroenterol. 20, 908\u2013922 (2014).","journal-title":"World J. Gastroenterol."},{"key":"286_CR166","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.chom.2016.11.010","volume":"21","author":"J Si","year":"2017","unstructured":"Si, J., You, H. J., Yu, J., Sung, J. & Ko, G. Prevotella as a hub for vaginal microbiota under the influence of host genetics and their association with obesity. Cell Host Microbe 21, 97\u2013105 (2017).","journal-title":"Cell Host Microbe"},{"key":"286_CR167","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.4014\/jmb.1710.10001","volume":"27","author":"S Choi","year":"2017","unstructured":"Choi, S., Hwang, Y. J., Shin, M. J. & Yi, H. Difference in the gut microbiome between ovariectomy-induced obesity and diet-induced obesity. J. Microbiol. Biotechnol. 27, 2228\u20132236 (2017).","journal-title":"J. Microbiol. Biotechnol."},{"key":"286_CR168","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.12488","volume":"3","author":"KA Cox-York","year":"2015","unstructured":"Cox-York, K. A. et al. Ovariectomy results in differential shifts in gut microbiota in low versus high aerobic capacity rats. Physiol. Rep. 3, e12488 (2015).","journal-title":"Physiol. Rep."},{"key":"286_CR169","doi-asserted-by":"publisher","first-page":"24380","DOI":"10.1038\/srep24380","volume":"6","author":"J Shen","year":"2016","unstructured":"Shen, J. et al. Effects of low dose estrogen therapy on the vaginal microbiomes of women with atrophic vaginitis. Sci. Rep. 6, 24380 (2016).","journal-title":"Sci. Rep."},{"key":"286_CR170","first-page":"djw029","volume":"108","author":"M Kwa","year":"2016","unstructured":"Kwa, M., Plottel, C. S., Blaser, M. J. & Adams, S. The intestinal microbiome and estrogen receptor-positive female breast cancer. J. Natl Cancer Inst. 108, djw029 (2016).","journal-title":"J. Natl Cancer Inst."},{"key":"286_CR171","doi-asserted-by":"crossref","unstructured":"Joshi, A. R. & Ellenson, L. H. in Molecular Genetics of Endometrial Carcinoma (ed L. H. Ellenson) 261\u2013273 (Springer, 2017).","DOI":"10.1007\/978-3-319-43139-0_9"},{"key":"286_CR172","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3322\/caac.21456","volume":"68","author":"LA Torre","year":"2018","unstructured":"Torre, L. A. et al. Ovarian cancer statistics, 2018. CA Cancer J. Clin. 68, 284\u2013296 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"286_CR173","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-38031-2","volume":"9","author":"B Zhou","year":"2019","unstructured":"Zhou, B. et al. The biodiversity composition of microbiome in ovarian carcinoma patients. Sci. Rep. 9, 1691 (2019).","journal-title":"Sci. Rep."},{"key":"286_CR174","doi-asserted-by":"crossref","first-page":"36225","DOI":"10.18632\/oncotarget.16717","volume":"8","author":"S Banerjee","year":"2017","unstructured":"Banerjee, S. et al. The ovarian cancer oncobiome. Oncotarget 8, 36225\u201336245 (2017).","journal-title":"Oncotarget"},{"key":"286_CR175","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1007\/s10096-012-1570-5","volume":"31","author":"S Shanmughapriya","year":"2012","unstructured":"Shanmughapriya, S. et al. Viral and bacterial aetiologies of epithelial ovarian cancer. Eur. J. Clin. Microbiol. Infect. Dis. 31, 2311\u20132317 (2012).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"286_CR176","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1006\/gyno.1996.0316","volume":"63","author":"PJ Chan","year":"1996","unstructured":"Chan, P. J., Seraj, I. M., Kalugdan, T. H. & King, A. Prevalence of mycoplasma conserved DNA in malignant ovarian cancer detected using sensitive PCR-ELISA. Gynecol. Oncol. 63, 258\u2013260 (1996).","journal-title":"Gynecol. Oncol."},{"key":"286_CR177","first-page":"257","volume":"6","author":"MM Emara","year":"2016","unstructured":"Emara, M. M. et al. Synchronous occurrence of brucellosis and ovarian cancer \u2014 a case report. Austral. Asian J. Cancer 6, 257\u2013259 (2016).","journal-title":"Austral. Asian J. Cancer"},{"key":"286_CR178","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11864-017-0504-y","volume":"18","author":"JB Pakish","year":"2017","unstructured":"Pakish, J. B. & Jazaeri, A. A. Immunotherapy in gynecologic cancers: are we there yet? Curr. Treat. Options Oncol. 18, 59 (2017).","journal-title":"Curr. Treat. Options Oncol."},{"key":"286_CR179","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy, B. et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359, 91\u201397 (2018).","journal-title":"Science"},{"key":"286_CR180","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.aao3290","volume":"359","author":"V Matson","year":"2018","unstructured":"Matson, V. et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 359, 104\u2013108 (2018).","journal-title":"Science"},{"key":"286_CR181","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan, V. et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359, 97\u2013103 (2018).","journal-title":"Science"},{"key":"286_CR182","doi-asserted-by":"publisher","unstructured":"Colbert, L. E. et al. The gut and cervical microbiome promote immune activation and response to chemoradiation in cervical cancer. Cancer Cell https:\/\/doi.org\/10.2139\/ssrn.3199993 (2018).","DOI":"10.2139\/ssrn.3199993"},{"key":"286_CR183","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.aac4255","volume":"350","author":"A Sivan","year":"2015","unstructured":"Sivan, A. et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350, 1084\u20131089 (2015).","journal-title":"Science"},{"key":"286_CR184","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrgastro.2017.20","volume":"14","author":"JL Alexander","year":"2017","unstructured":"Alexander, J. L. et al. Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat. Rev. Gastroenterol. Hepatol. 14, 356\u2013365 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"286_CR185","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.maturitas.2018.03.012","volume":"112","author":"EM Wilkinson","year":"2018","unstructured":"Wilkinson, E. M., Ilhan, Z. E. & Herbst-Kralovetz, M. M. Microbiota-drug interactions: impact on metabolism and efficacy of therapeutics. Maturitas 112, 53\u201363 (2018).","journal-title":"Maturitas"},{"key":"286_CR186","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00280-010-1310-4","volume":"67","author":"A Kurita","year":"2011","unstructured":"Kurita, A. et al. Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of beta-glucuronidase activity in intestinal lumen. Cancer Chemother. Pharmacol. 67, 201\u2013213 (2011).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"286_CR187","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","volume":"350","author":"M Vetizou","year":"2015","unstructured":"Vetizou, M. et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350, 1079\u20131084 (2015).","journal-title":"Science"},{"key":"286_CR188","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nri3430","volume":"13","author":"N Kamada","year":"2013","unstructured":"Kamada, N., Seo, S. U., Chen, G. Y. & Nunez, G. Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 13, 321\u2013335 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"286_CR189","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/lam.12436","volume":"61","author":"S Wong","year":"2015","unstructured":"Wong, S. & Slavcev, R. A. Treating cancer with infection: a review on bacterial cancer therapy. Lett. Appl. Microbiol. 61, 107\u2013112 (2015).","journal-title":"Lett. Appl. Microbiol."},{"key":"286_CR190","doi-asserted-by":"publisher","first-page":"99545","DOI":"10.1172\/jci.insight.99545","volume":"3","author":"E Taneva","year":"2018","unstructured":"Taneva, E. et al. Vaginal microbiome modulates topical antiretroviral drug pharmacokinetics. JCI Insight 3, 99545 (2018).","journal-title":"JCI Insight"},{"key":"286_CR191","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217229","volume":"14","author":"AR Thurman","year":"2019","unstructured":"Thurman, A. R. et al. Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir\/levonorgestrel vaginal rings. PLoS One 14, e0217229 (2019).","journal-title":"PLoS One"},{"key":"286_CR192","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1093\/infdis\/jix420","volume":"216","author":"R Donahue Carlson","year":"2017","unstructured":"Donahue Carlson, R. et al. The female genital tract microbiome is associated with vaginal antiretroviral drug concentrations in human immunodeficiency virus-infected women on antiretroviral therapy. J. Infect. Dis. 216, 990\u2013999 (2017).","journal-title":"J. Infect. Dis."},{"key":"286_CR193","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1007\/s10096-015-2490-y","volume":"34","author":"B Vitali","year":"2015","unstructured":"Vitali, B. et al. Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis. Eur. J. Clin. Microbiol. Infect. Dis. 34, 2367\u20132376 (2015).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"286_CR194","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0305-7372(03)00117-8","volume":"29","author":"JH Maduro","year":"2003","unstructured":"Maduro, J. H., Pras, E., Willemse, P. H. & de Vries, E. G. Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. Cancer Treat. Rev. 29, 471\u2013488 (2003).","journal-title":"Cancer Treat. Rev."},{"key":"286_CR195","first-page":"381","volume":"82","author":"FJ Berkey","year":"2010","unstructured":"Berkey, F. J. Managing the adverse effects of radiation therapy. Am. Fam. Physician 82, 381\u2013388, 394 (2010).","journal-title":"Am. Fam. Physician"},{"key":"286_CR196","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/IJWH.S106796","volume":"9","author":"L Morris","year":"2017","unstructured":"Morris, L., Do, V., Chard, J. & Brand, A. H. Radiation-induced vaginal stenosis: current perspectives. Int. J. Womens Health 9, 273\u2013279 (2017).","journal-title":"Int. J. Womens Health"},{"key":"286_CR197","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083644","volume":"9","author":"XB Lin","year":"2014","unstructured":"Lin, X. B. et al. The role of intestinal microbiota in development of irinotecan toxicity and in toxicity reduction through dietary fibres in rats. PLoS One 9, e83644 (2014).","journal-title":"PLoS One"},{"key":"286_CR198","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1158\/1078-0432.CCR-05-0750","volume":"12","author":"G Brandi","year":"2006","unstructured":"Brandi, G. et al. Intestinal microflora and digestive toxicity of irinotecan in mice. Clin. Cancer Res. 12, 1299\u20131307 (2006).","journal-title":"Clin. Cancer Res."},{"key":"286_CR199","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1002\/ijc.31836","volume":"144","author":"KR Secombe","year":"2019","unstructured":"Secombe, K. R., Coller, J. K., Gibson, R. J., Wardill, H. R. & Bowen, J. M. The bidirectional interaction of the gut microbiome and the innate immune system: Implications for chemotherapy-induced gastrointestinal toxicity. Int. J. Cancer 144, 2365\u20132376 (2019).","journal-title":"Int. J. Cancer"},{"key":"286_CR200","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1007\/s00520-013-1741-7","volume":"21","author":"AM Stringer","year":"2013","unstructured":"Stringer, A. M. et al. Biomarkers of chemotherapy-induced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinases. Support. Care Cancer 21, 1843\u20131852 (2013).","journal-title":"Support. Care Cancer"},{"key":"286_CR201","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0140-6736(10)60893-8","volume":"376","author":"MW Audeh","year":"2010","unstructured":"Audeh, M. W. et al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial. Lancet 376, 245\u2013251 (2010).","journal-title":"Lancet"},{"key":"286_CR202","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.2147\/DDDT.S164553","volume":"12","author":"Y Liu","year":"2018","unstructured":"Liu, Y., Meng, J. & Wang, G. Risk of selected gastrointestinal toxicities associated with poly (ADP-ribose) polymerase (PARP) inhibitors in the treatment of ovarian cancer: a meta-analysis of published trials. Drug. Des. Devel. Ther. 12, 3013\u20133019 (2018).","journal-title":"Drug. Des. Devel. Ther."},{"key":"286_CR203","first-page":"4335","volume":"18","author":"A Vida","year":"2018","unstructured":"Vida, A., Kardos, G., Kovacs, T., Bodrogi, B. L. & Bai, P. Deletion of poly(ADPribose) polymerase-1 changes the composition of the microbiome in the gut. Mol. Med. Rep. 18, 4335\u20134341 (2018).","journal-title":"Mol. Med. Rep."},{"key":"286_CR204","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1126\/science.1191175","volume":"330","author":"BD Wallace","year":"2010","unstructured":"Wallace, B. D. et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 330, 831\u2013835 (2010).","journal-title":"Science"},{"key":"286_CR205","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/apt.12878","volume":"40","author":"Y Touchefeu","year":"2014","unstructured":"Touchefeu, Y. et al. Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis \u2014 current evidence and potential clinical applications. Aliment. Pharmacol. Ther. 40, 409\u2013421 (2014).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"286_CR206","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33469-w","volume":"8","author":"R Carvalho","year":"2018","unstructured":"Carvalho, R. et al. Gut microbiome modulation during treatment of mucositis with the dairy bacterium Lactococcus lactis and recombinant strain secreting human antimicrobial PAP. Sci. Rep. 8, 15072 (2018).","journal-title":"Sci. Rep."},{"key":"286_CR207","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40425-018-0332-z","volume":"6","author":"FZ Acero Brand","year":"2018","unstructured":"Acero Brand, F. Z. et al. Severe immune mucositis and esophagitis in metastatic squamous carcinoma of the larynx associated with pembrolizumab. J. Immunother. Cancer 6, 22 (2018).","journal-title":"J. Immunother. Cancer"},{"key":"286_CR208","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/0360-3016(93)90455-5","volume":"27","author":"DW Bruner","year":"1993","unstructured":"Bruner, D. W. et al. Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 27, 825\u2013830 (1993).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"286_CR209","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4065\/mcp.2009.0413","volume":"85","author":"MB Mac Bride","year":"2010","unstructured":"Mac Bride, M. B., Rhodes, D. J. & Shuster, L. T. Vulvovaginal atrophy. Mayo Clin. Proc. 85, 87\u201394 (2010).","journal-title":"Mayo Clin. Proc."},{"key":"286_CR210","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s00520-018-4441-5","volume":"27","author":"JM Stahl","year":"2019","unstructured":"Stahl, J. M. et al. Extended duration of dilator use beyond 1 year may reduce vaginal stenosis after intravaginal high-dose-rate brachytherapy. Support. Care Cancer 27, 1425\u20131433 (2019).","journal-title":"Support. Care Cancer"},{"key":"286_CR211","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/clon.1999.9008","volume":"11","author":"SB Decruze","year":"1999","unstructured":"Decruze, S. B., Guthrie, D. & Magnani, R. Prevention of vaginal stenosis in patients following vaginal brachytherapy. Clin. Oncol. 11, 46\u201348 (1999).","journal-title":"Clin. Oncol."},{"key":"286_CR212","first-page":"E48","volume":"46","author":"J Bai","year":"2019","unstructured":"Bai, J., Jhaney, I., Daniel, G. & Watkins Bruner, D. Pilot study of vaginal microbiome using QIIME 2 in women with gynecologic cancer before and after radiation therapy. Oncol. Nurs. Forum 46, E48\u2013E59 (2019).","journal-title":"Oncol. Nurs. Forum"},{"key":"286_CR213","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.crohns.2014.08.006","volume":"8","author":"RJ Colman","year":"2014","unstructured":"Colman, R. J. & Rubin, D. T. Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J. Crohns Colitis 8, 1569\u20131581 (2014).","journal-title":"J. Crohns Colitis"},{"key":"286_CR214","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1093\/cid\/cir632","volume":"53","author":"E Gough","year":"2011","unstructured":"Gough, E., Shaikh, H. & Manges, A. R. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin. Infect. Dis. 53, 994\u20131002 (2011).","journal-title":"Clin. Infect. Dis."},{"key":"286_CR215","unstructured":"Weiman, S. Harnessing the power of microbes as therapeutics: bugs as drugs. Report on an American Academy of Microbiology Colloquium held in San Diego, CA, in April 2014 (ed. Fox J.) (American Society for Microbiology, 2015)."},{"key":"286_CR216","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1053\/j.gastro.2018.03.060","volume":"154","author":"P Biancheri","year":"2018","unstructured":"Biancheri, P., Divekar, D. & Watson, A. J. M. Could fecal transplantation become part of PD-1-based immunotherapy, due to effects of the intestinal microbiome? Gastroenterology 154, 1845\u20131847 (2018).","journal-title":"Gastroenterology"},{"key":"286_CR217","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3389\/fimmu.2018.00374","volume":"9","author":"Y Wang","year":"2018","unstructured":"Wang, Y., Ma, R., Liu, F., Lee, S. A. & Zhang, L. Modulation of gut microbiota: a novel paradigm of enhancing the efficacy of programmed death-1 and programmed death ligand-1 blockade therapy. Front. Immunol. 9, 374 (2018).","journal-title":"Front. Immunol."},{"key":"286_CR218","doi-asserted-by":"publisher","first-page":"ofv004","DOI":"10.1093\/ofid\/ofv004","volume":"2","author":"N Alang","year":"2015","unstructured":"Alang, N. & Kelly, C. R. Weight gain after fecal microbiota transplantation. Open Forum Infect. Dis. 2, ofv004 (2015).","journal-title":"Open Forum Infect. Dis."},{"key":"286_CR219","doi-asserted-by":"publisher","first-page":"G310","DOI":"10.1152\/ajpgi.00282.2013","volume":"306","author":"AR Weingarden","year":"2014","unstructured":"Weingarden, A. R. et al. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am. J. Physiol. Gastrointest. Liver Physiol. 306, G310\u2013G319 (2014).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"286_CR220","doi-asserted-by":"publisher","first-page":"448","DOI":"10.15252\/emmm.201606932","volume":"9","author":"M Cui","year":"2017","unstructured":"Cui, M. et al. Faecal microbiota transplantation protects against radiation-induced toxicity. EMBO Mol. Med. 9, 448\u2013461 (2017).","journal-title":"EMBO Mol. Med."},{"key":"286_CR221","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.mayocp.2017.08.016","volume":"92","author":"M Hefazi","year":"2017","unstructured":"Hefazi, M. et al. Safety and efficacy of fecal microbiota transplant for recurrent Clostridium difficile infection in patients with cancer treated with cytotoxic chemotherapy: a single-institution retrospective case series. Mayo Clin. Proc. 92, 1617\u20131624 (2017).","journal-title":"Mayo Clin. Proc."},{"key":"286_CR222","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.ebiom.2019.03.070","volume":"44","author":"HR Wardill","year":"2019","unstructured":"Wardill, H. R., Secombe, K. R., Bryant, R. V., Hazenberg, M. D. & Costello, S. P. Adjunctive fecal microbiota transplantation in supportive oncology: emerging indications and considerations in immunocompromised patients. EBioMedicine 44, 730\u2013740 (2019).","journal-title":"EBioMedicine"},{"key":"286_CR223","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/19490976.2016.1234657","volume":"7","author":"AB Javurek","year":"2016","unstructured":"Javurek, A. B. et al. Effects of exposure to bisphenol A and ethinyl estradiol on the gut microbiota of parents and their offspring in a rodent model. Gut Microbes 7, 471\u2013485 (2016).","journal-title":"Gut Microbes"},{"key":"286_CR224","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.it.2013.01.005","volume":"34","author":"P van Baarlen","year":"2013","unstructured":"van Baarlen, P., Wells, J. M. & Kleerebezem, M. Regulation of intestinal homeostasis and immunity with probiotic lactobacilli. Trends Immunol. 34, 208\u2013215 (2013).","journal-title":"Trends Immunol."},{"key":"286_CR225","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1097\/OLQ.0b013e3182267ac4","volume":"38","author":"BM Ngugi","year":"2011","unstructured":"Ngugi, B. M. et al. Effects of bacterial vaginosis-associated bacteria and sexual intercourse on vaginal colonization with the probiotic Lactobacillus crispatus CTV-05. Sex. Transm. Dis. 38, 1020\u20131027 (2011).","journal-title":"Sex. Transm. Dis."},{"key":"286_CR226","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/OLQ.0b013e3181e50026","volume":"37","author":"A Hemmerling","year":"2010","unstructured":"Hemmerling, A. et al. Phase 2a study assessing colonization efficiency, safety, and acceptability of Lactobacillus crispatus CTV-05 in women with bacterial vaginosis. Sex. Transm. Dis. 37, 745\u2013750 (2010).","journal-title":"Sex. Transm. Dis."},{"key":"286_CR227","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/cid\/cir183","volume":"52","author":"AE Stapleton","year":"2011","unstructured":"Stapleton, A. E. et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin. Infect. Dis. 52, 1212\u20131217 (2011).","journal-title":"Clin. Infect. Dis."},{"key":"286_CR228","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/cid\/ciy554","volume":"68","author":"JM Marrazzo","year":"2019","unstructured":"Marrazzo, J. M. et al. Safety and efficacy of a novel vaginal anti-infective, TOL-463, in the treatment of bacterial vaginosis and vulvovaginal candidiasis: a randomized, single-blind, phase 2, controlled trial. Clin. Infect. Dis. 68, 803\u2013809 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"286_CR229","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1089\/jwh.2017.6500","volume":"27","author":"SE Chavoustie","year":"2018","unstructured":"Chavoustie, S. E., Gersten, J. K., Samuel, M. J. & Schwebke, J. R. A phase 3, multicenter, prospective, open-label study to evaluate the safety of a single dose of secnidazole 2 g for the treatment of women and postmenarchal adolescent girls with bacterial vaginosis. J. Womens Health 27, 492\u2013497 (2018).","journal-title":"J. Womens Health"},{"key":"286_CR230","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/s41591-019-0600-6","volume":"25","author":"A Lev-Sagie","year":"2019","unstructured":"Lev-Sagie, A. et al. Vaginal microbiome transplantation in women with intractable bacterial vaginosis. Nat. Med. 25, 1500\u20131504 (2019).","journal-title":"Nat. Med."},{"key":"286_CR231","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3389\/fcimb.2019.00306","volume":"9","author":"K DeLong","year":"2019","unstructured":"DeLong, K. et al. Conceptual design of a universal donor screening approach for vaginal microbiota transplant. Front. Cell Infect. Microbiol. 9, 306 (2019).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"286_CR232","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1136\/gutjnl-2019-318556","volume":"68","author":"AJ Scott","year":"2019","unstructured":"Scott, A. J. et al. International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis. Gut 68, 1624\u20131632 (2019).","journal-title":"Gut"},{"key":"286_CR233","doi-asserted-by":"crossref","unstructured":"Lokken, E. M. et al. Association between vaginal washing and detection of Lactobacillus by culture and quantitative PCR in HIV-seronegative Kenyan women: a cross-sectional analysis. Sex Transm. Infect. (2019).","DOI":"10.1136\/sextrans-2018-053769"},{"key":"286_CR234","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nature24460","volume":"551","author":"D Vandeputte","year":"2017","unstructured":"Vandeputte, D. et al. Quantitative microbiome profiling links gut community variation to microbial load. Nature 551, 507\u2013511 (2017).","journal-title":"Nature"},{"key":"286_CR235","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1038\/onc.2013.321","volume":"33","author":"E Lengyel","year":"2014","unstructured":"Lengyel, E. et al. Epithelial ovarian cancer experimental models. Oncogene 33, 3619\u20133633 (2014).","journal-title":"Oncogene"}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41585-020-0286-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41585-020-0286-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41585-020-0286-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T19:28:07Z","timestamp":1722454087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41585-020-0286-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,18]]},"references-count":235,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["286"],"URL":"https:\/\/doi.org\/10.1038\/s41585-020-0286-z","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,18]]},"assertion":[{"value":"17 January 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.M.H.-K. has been a consultant for Lupin Pharmaceuticals and Beckton Dickinson. P.\u0141. and Z.E.I. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}